CRBU FY 2025 Earnings — Caribou Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CRBUCaribou Biosciences, Inc.

$186M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$11M+11.7% YoY

Gross Profit

$8M67.3% margin

Operating Income

-$136M-1220.5% margin

Net Income

-$148M-1327.4% margin

EPS (Diluted)

$-1.59

Cash Flow

Operating Cash Flow

-$111M

Free Cash Flow

-$112M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$175M

Total Liabilities

$53M

Stockholders' Equity

$122M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$10M	+11.7%
Gross Profit	$8M	$6M	+23.9%
Operating Income	-$136M	-$167M	+18.3%
Net Income	-$148M	-$149M	+0.7%